Literature DB >> 18236142

Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Stuart J Frank1.   

Abstract

Growth hormone (GH) and prolactin (PRL) are anterior pituitary hormones that have multiple roles in growth and metabolism. Both hormones are important in mammary development and breast cancer. The epidermal growth factor (EGF) family of peptides and the receptors that they activate (the ErbB family) are also major players in mammary biology and pathophysiology. Recent studies in signal transduction have highlighted the interplay between signaling pathways referred to as crosstalk. In this review, cell biological and signaling studies related to crosstalk between GH and PRL and the ErbB family are discussed. In particular, the role of GH- and PRL-induced phosphorylation of ErbB receptors in regulating EGF responsiveness is highlighted with attention to potential pathophysiological relevance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18236142     DOI: 10.1007/s10911-008-9065-9

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  131 in total

1.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

2.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

3.  Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.

Authors:  S O Kim; J C Houtman; J Jiang; J M Ruppert; P J Bertics; S J Frank
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

4.  Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.

Authors:  S J Frank; G Gilliland; A S Kraft; C S Arnold
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

5.  Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Authors:  Y Huang; X Li; J Jiang; S J Frank
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

6.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

Review 7.  Prolactin as an autocrine/paracrine growth factor in human cancer.

Authors:  Nira Ben-Jonathan; Karen Liby; Molly McFarland; Michael Zinger
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

8.  Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha.

Authors:  Declan F McCole; Stephen J Keely; Robert J Coffey; Kim E Barrett
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

9.  Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.

Authors:  I C Northwood; F A Gonzalez; M Wartmann; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

10.  Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.

Authors:  R W McMurray; D Weidensaul; S H Allen; S E Walker
Journal:  J Rheumatol       Date:  1995-11       Impact factor: 4.666

View more
  7 in total

Review 1.  Prolactin: The Third Hormone in Breast Cancer.

Authors:  Linda A Schuler; Kathleen A O'Leary
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 2.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

Review 3.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

4.  Complex prolactin crosstalk in breast cancer: new therapeutic implications.

Authors:  Kristopher C Carver; Lisa M Arendt; Linda A Schuler
Journal:  Mol Cell Endocrinol       Date:  2009-04-01       Impact factor: 4.102

Review 5.  The Mammary Gland: Basic Structure and Molecular Signaling during Development.

Authors:  Swarajit Kumar Biswas; Saswati Banerjee; Ginger Wendolyn Baker; Chieh-Yin Kuo; Indrajit Chowdhury
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 6.208

6.  GH mediates exercise-dependent activation of SVZ neural precursor cells in aged mice.

Authors:  Daniel G Blackmore; Jana Vukovic; Michael J Waters; Perry F Bartlett
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

7.  EGFR signaling promotes β-cell proliferation and survivin expression during pregnancy.

Authors:  Elina Hakonen; Jarkko Ustinov; Jaan Palgi; Päivi J Miettinen; Timo Otonkoski
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.